Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

143
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
143
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

597
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
597
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

170
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
170
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

692
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
692
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

103
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
103
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

250
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
250

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bayesian Covariate-Dependent Circadian Modeling of Rest-Activity Rhythms.

Data science in science·2026
Same author

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026
Same author

Cannabis Use and Tooth Loss by Race and Sexual Orientation/Gender Identity.

AJPM focus·2026
Same author

Development and usability testing of a mindfulness-based smoking cessation app for adults with low income: "It's helped me to not react and grab a cigarette".

Journal of health psychology·2026
Same author

Sociodemographic Paradoxes and Enrollment Differences in In-Person Versus Online Recruitment to a Mobile Health Smoking Cessation Intervention for Food-Insecure Adults: Secondary Analysis of a Randomized Controlled Trial.

Journal of medical Internet research·2026
Same author

Modes of cannabis administration, cannabis and tobacco co-use, and associations with respiratory and cannabis use outcomes in a permissive medical cannabis state.

Addictive behaviors·2026

Related Experiment Video

Updated: Oct 9, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Bayesian continuous-time hidden Markov models with covariate selection for intensive longitudinal data with

Mingrui Liang1, Matthew D Koslovsky2, Emily T Hébert3

  • 1Department of Statistics, Rice University.

Psychological Methods
|December 20, 2021
PubMed
Summary

This study introduces a Bayesian hidden Markov model to analyze ecological momentary assessment data, accounting for misreporting and improving accuracy in behavioral research. The model enhances understanding of risk factors in real-time data collection.

More Related Videos

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.5K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.4K

Related Experiment Videos

Last Updated: Oct 9, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.5K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.4K

Area of Science:

  • Behavioral Science
  • Statistical Modeling
  • Psychological Measurement

Background:

  • Ecological momentary assessment (EMA) provides real-time data but is prone to self-report biases like measurement error and social desirability bias.
  • Traditional analyses may not adequately address these biases, potentially impacting the accuracy of identified risk factors.
  • Accurate analysis of EMA data is crucial for understanding behavior change and intervention effectiveness.

Purpose of the Study:

  • To develop and validate a Bayesian hidden Markov model (BHMM) capable of simultaneously identifying risk factors for state transitions and potential misreporting in EMA data.
  • To assess the impact of measurement error on variable selection and estimation accuracy using simulated data.
  • To apply the BHMM to real-world EMA data from a smoking cessation trial.

Main Methods:

  • Development of a Bayesian hidden Markov model incorporating latent states and measurement error.
  • Simulation studies to evaluate model performance under varying conditions of measurement error.
  • Application of the BHMM to smartphone-based EMA data from a randomized controlled trial on smoking abstinence.

Main Results:

  • Simulations demonstrated that ignoring measurement error can lead to inaccurate variable selection and estimation.
  • The BHMM successfully identified risk factors associated with state transitions and potential misreporting in the smoking cessation trial data.
  • The model provides a more robust approach to analyzing complex EMA data compared to methods that ignore measurement error.

Conclusions:

  • The proposed Bayesian hidden Markov model offers a powerful tool for analyzing intensive longitudinal data, effectively addressing biases inherent in self-reported measures.
  • Accounting for measurement error is essential for accurate identification of risk factors and reliable conclusions from EMA studies.
  • This methodology can enhance the validity of findings in behavioral and psychological research utilizing EMA.